Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed director
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Appointed COO
BRAINSTORM CELL THERAPEUTICS INC. (BCLI) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/23/2020 GN Catalent et BrainStorm Cell Therapeutics annoncent un partenariat pour la conception de la plateforme de thérapie par cellules souches mésenchymateuses NurOwn®
10/23/2020 GN Catalent und BrainStorm Cell Therapeutics geben Partnerschaft zur Herstellung von NurOwn®, einer auf mesenchymalen Stammzellen beruhenden Therapie, bekannt
10/22/2020 GN Catalent and BrainStorm Cell Therapeutics Announce Partnership for the Manufacture of Mesenchymal Stem Cell Platform Therapy NurOwn®
05/07/2020 GN BrainStorm Announces Financial Results for the First Quarter of 2020 and Provides a Corporate Update
05/07/2020 GN BrainStorm Leases a New Cleanroom Facility at The Tel Aviv Sourasky Medical Center to Manufacture NurOwn® for The European Union
05/04/2020 GN BrainStorm Presents New Data Highlighting NurOwn® Immunomodulation in Neurology
04/29/2020 GN BrainStorm-Cell Therapeutics to Announce First Quarter Financial Results and Provide a Corporate Update
04/03/2020 GN BrainStorm Awarded $1.5 Million Non-Dilutive Grant for 2020 by the Israel Innovation Authority
04/01/2020 GN David Setboun Joins BrainStorm as Executive Vice President and Chief Operating Officer
03/31/2020 GN BrainStorm Appoints Renowned Distinguished Economist, Prof. Jacob Frenkel, Chairman of the Board of Directors
02/27/2020 GN Fifth and Final Site Announced for BrainStorm's Progressive Multiple Sclerosis Phase 2 Clinical Trial
02/17/2020 GN BrainStorm's Chief Operating Officer to Present at Noble Capital Markets' Sixteenth Annual Investor Conference
01/29/2020 GN BrainStorm Receives Notice of Intention to Grant Additional EU patent for NurOwn®
01/07/2020 GN BrainStorm Cell Therapeutics to Present at the 2020 Biotech Showcase and 3rd Annual Neuroscience Innovation Forum at JPM Week
12/19/2019 GN NurOwn® Data Safety Monitoring Board Recommends MS Phase 2 Clinical Trial Continue
12/18/2019 GN BrainStorm Issues 2019 Letter to Shareholders
11/26/2019 GN BrainStorm Cell Therapeutics to make scientific presentations at the 30th International Symposium on ALS/MND
11/25/2019 GN BrainStorm Announces the Mount Sinai Medical Center as a Progressive MS Phase 2 Clinical Trial Site
11/20/2019 GN BrainStorm Cell Therapeutics Announces Publication of NurOwn® ALS Phase 2 Randomized Clinical Trial Data in Neurology
11/14/2019 GN BrainStorm Cell Therapeutics Announces Research Grant Award From the National Multiple Sclerosis Society
11/14/2019 GN BrainStorm Announces Financial Results for the Third Quarter of 2019 and Provides a Corporate Update
11/13/2019 GN BrainStorm Announces Grant of a New Japanese Patent for NurOwn®
11/12/2019 GN BrainStorm Cell Therapeutics Announces Ralph Kern MD MHSc to Present at the 7th International Stem Cell Meeting
11/05/2019 GN BrainStorm Cell Therapeutics to Announce Third Quarter Financial Results and Provide a Comprehensive Corporate Update
10/25/2019 GN BrainStorm Cell Therapeutics to Present at the Dawson James Securities 5th Annual Small Cap Growth Conference
10/24/2019 GN BrainStorm Cell Therapeutics' President and CEO to be Featured as Keynote Speaker at Cell Series UK 2019
10/23/2019 GN BrainStorm Cell Therapeutics Presentations at Neuromuscular Drug Development Summit
10/11/2019 GN BrainStorm's NurOwn® Phase 3 ALS Clinical Trial Now Fully Enrolled
10/02/2019 GN BrainStorm Cell Therapeutics to Present NurOwn® Phase 2 Biomarker Data at North East Amyotrophic Lateral Sclerosis (NEALS) 18th Annual Meeting
09/27/2019 GN BrainStorm Cell Therapeutics Announces Support for FDA Guidelines on ALS Drug Development
09/09/2019 GN BrainStorm Strengthens Senior Executive Management Team with the Appointment of Preetam Shah, Ph.D., M.B.A., as Chief Financial Officer
09/06/2019 GN BrainStorm Cell Therapeutics to Present Late Breaking News ePoster at the 35th ECTRIMS Congress
08/13/2019 GN BrainStorm Announces Financial Results for the Second Quarter of 2019 and Provides a Corporate Update
05/31/2019 GN BrainStorm Presents Poster at Consortium of Multiple Sclerosis Centers (CMSC) 33rd Annual Meeting
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy